{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:43:20Z","timestamp":1790739800322,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.encep.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T12:09:05Z","timestamp":1473768545000},"page":"568-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Int\u00e9r\u00eat d\u2019un traitement par scopolamine dans les troubles d\u00e9pressifs"],"prefix":"10.1016","volume":"42","author":[{"given":"A.","family":"Rigal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mouchabac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Peretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.encep.2016.06.002_bib0150","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archpsyc.62.10.1097","article-title":"Epidemiology of major depressive disorder results from the national epidemiologic survey on alcoholism and related conditions","volume":"62","author":"Hasin","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"23","key":"10.1016\/j.encep.2016.06.002_bib0155","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder. Results from the national comorbidity survey replication","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.encep.2016.06.002_bib0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0197-2456(03)00112-0","article-title":"Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design","volume":"25","author":"Rush","year":"2004","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.encep.2016.06.002_bib0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0924-977X(98)00004-2","article-title":"Treatment resistant depression: methodological overview and operational criteria","volume":"9","author":"Souery","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2016.06.002_bib0170","first-page":"23","article-title":"When at first you don\u2019t succeed: sequential strategies for antidepressant non responders","volume":"58","author":"Thase","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2016.06.002_bib0175","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4088\/JCP.v60n0302","article-title":"The texas medication algorithm project: report of the texas consensus conference panel on medication treatment of major depressive disorder","volume":"60","author":"Crismon","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2016.06.002_bib0180","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archpsyc.63.10.1121","article-title":"Antidepressant efficacy of the antimuscarinic drug scopolamine","volume":"63","author":"Furey","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2016.06.002_bib0185","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biopsych.2012.09.031","article-title":"Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review","volume":"73","author":"Drevets","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.encep.2016.06.002_bib0190","first-page":"17","article-title":"The antidepressant effects of anticholinergic drugs","volume":"47","author":"Howland","year":"2009","journal-title":"J Psychosoc Nurs"},{"issue":"2","key":"10.1016\/j.encep.2016.06.002_bib0195","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1124\/jpet.114.216804","article-title":"M1\u00a0and M2\u00a0muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamine","volume":"351","author":"Witkin","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.encep.2016.06.002_bib0200","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biopsych.2009.11.021","article-title":"Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial","volume":"67","author":"Drevets","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.encep.2016.06.002_bib0205","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0163-8343(96)00004-7","article-title":"Physostigmine temporarily and dramatically reversing acute mania","volume":"18","author":"Khouzam","year":"1996","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.encep.2016.06.002_bib0210","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1073\/pnas.1219731110","article-title":"Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety and depression like behavior","volume":"9","author":"Mineur","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.encep.2016.06.002_bib0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00213-010-2153-8","article-title":"Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings","volume":"215","author":"Graef","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.encep.2016.06.002_bib0220","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4088\/JCP.12m07706","article-title":"Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double blind, placebo-controlled study","volume":"73","author":"Khajavi","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2016.06.002_bib0225","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.mp.4001021","article-title":"Glutamate and GABA systems as target for novel antidepressant and mood-stabilizing treatments","volume":"7","author":"Krystal","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.encep.2016.06.002_bib0230","first-page":"1101","article-title":"Novel glutamatergic drugs for the treatment of mood disorders","volume":"9","author":"Lapidus","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.encep.2016.06.002_bib0235","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/npp.2010.131","article-title":"scopolamine produces larger antidepressant and anti anxiety effects in women than in men","volume":"35","author":"Furey","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.encep.2016.06.002_bib0240","doi-asserted-by":"crossref","first-page":"e32082","DOI":"10.1371\/journal.pone.0032082","article-title":"scopolamine administration modulates muscarinic, nicotinic and NMDA receptor system","volume":"7","author":"Falsafi","year":"2012","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.encep.2016.06.002_bib0245","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S1461145704004328","article-title":"REM sleep and cortisol responses to scopolamine during depression and remission in women","volume":"7","author":"Rao","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.encep.2016.06.002_bib0250","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0893-133X(99)00067-6","article-title":"Age-related effects of scopolamine on REM sleep regulation in normal control subjects: relationship to sleep abnormalities in depression","volume":"21","author":"Rao","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.encep.2016.06.002_bib0255","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.mp.4001035","article-title":"Nicotinic acetylcholine receptors as targets for antidepressants","volume":"7","author":"Shytle","year":"2002","journal-title":"Mol Psychiatry"},{"issue":"10","key":"10.1016\/j.encep.2016.06.002_bib0260","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.biopsych.2013.04.025","article-title":"scopolamine rapidly increases mammalian target of rapamycin complex 1\u00a0signaling, synaptognesis, and antidepressant behavioral responses","volume":"74","author":"Voleti","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.encep.2016.06.002_bib0265","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/1871527313666140618105710","article-title":"Scopolamine and depression: a role for muscarinic antagonism?","volume":"13","author":"Hasselman","year":"2014","journal-title":"CNS Neurol Drug Targets"},{"issue":"1","key":"10.1016\/j.encep.2016.06.002_bib0270","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.psychres.2012.01.003","article-title":"Baseline mood-state measures as predictors of antidepressant response to scopolamine","volume":"196","author":"Furey","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2016.06.002_bib0275","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/2013.jamapsychiatry.60","article-title":"Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder","volume":"70","author":"Furey","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.encep.2016.06.002_bib0280","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3109\/07853890.2011.583675","article-title":"Therapeutic options in treatment-resistant depression","volume":"43","author":"Vieta","year":"2011","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.encep.2016.06.002_bib0285","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.encep.2013.09.002","article-title":"Effet antid\u00e9presseur de la k\u00e9tamine\u00a0: revue de la litt\u00e9rature sur l\u2019utilisation de la k\u00e9tamine dans la d\u00e9pression","volume":"40","author":"De Maricourt","year":"2014","journal-title":"Encephale"},{"issue":"10","key":"10.1016\/j.encep.2016.06.002_bib0145","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two site randomized controlled clinical trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370061630135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001370061630135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T09:51:50Z","timestamp":1536400310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001370061630135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S001370061630135X"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2016.06.002","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Int\u00e9r\u00eat d\u2019un traitement par scopolamine dans les troubles d\u00e9pressifs","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}